Literature DB >> 2984648

Testicular germ cell tumours--a model for a new approach to treatment of adult solid tumours.

R T Oliver.   

Abstract

Entities:  

Mesh：

Year:  1985        PMID： 2984648      PMCID： PMC2418154          DOI： 10.1136/pgmj.61.712.123

Source DB:  PubMed          Journal:  Postgrad Med J        ISSN： 0032-5473            Impact factor:   2.401


× No keyword cloud information.
  29 in total

1.  Diaminodichloroplatinum: a phase I study showing responses in testicular and other tumors.

Authors:  D J Higby; H J Wallace; D J Albert; J F Holland
Journal:  Cancer       Date:  1974-05       Impact factor: 6.860

2.  Justification of the use of surveillance in the management of Stage I germ cell tumours of the testis.

Authors:  R T Oliver; H F Hope-Stone; J P Blandy
Journal:  Br J Urol       Date:  1983-12

3.  Combination chemotherapy in germinal cell tumors.

Authors:  M L Samuels; V J Lanzotti; P Y Holoye; L E Boyle; T L Smith; D E Johnson
Journal:  Cancer Treat Rev       Date:  1976-12       Impact factor: 12.111

4.  Testicular cancer, histologic classification and staging, topography of lymph node metastases.

Authors:  P Hermanek
Journal:  Recent Results Cancer Res       Date:  1977

5.  Placental alkaline phosphatase as a tumor marker for seminoma.

Authors:  P H Lange; J L Millan; T Stigbrand; R L Vessella; E Ruoslahti; W H Fishman
Journal:  Cancer Res       Date:  1982-08       Impact factor: 12.701

6.  Possible new approaches to the management of seminoma of the testis.

Authors:  R T Oliver; H F Hope-Stone; J P Blandy
Journal:  Br J Urol       Date:  1984-12

7.  Chemotherapy of disseminated testicular cancer. A random prospective study.

Authors:  L H Einhorn; S D Williams
Journal:  Cancer       Date:  1980-09-15       Impact factor: 6.860

8.  Combined management of malignant teratoma of the testis.

Authors:  M J Peckham; T J McElwain; A Barrett; W F Hendry
Journal:  Lancet       Date:  1979-08-11       Impact factor: 79.321

9.  VAB-6 combination chemotherapy without maintenance in treatment of disseminated cancer of the testis.

Authors:  D Vugrin; W F Whitmore; R B Golbey
Journal:  Cancer       Date:  1983-01-15       Impact factor: 6.860

10.  Chemotherapy of advanced malignant teratomas.

Authors:  E S Newlands; R H Begent; S B Kaye; G J Rustin; K D Bagshawe
Journal:  Br J Cancer       Date:  1980-09       Impact factor: 7.640
View more
  5 in total

1.  Testicular self-examination: is it still necessary.

Authors:  K P Dieckmann
Journal:  Postgrad Med J       Date:  1988-03       Impact factor: 2.401

2.  Recent trends in mortality due to testicular cancer in Ireland: a comparison with England and Wales.

Authors:  J A Thornhill; R M Conroy; D G Kelly; A Walsh; J J Fennelly; J M Fitzpatrick
Journal:  J Epidemiol Community Health       Date:  1986-09       Impact factor: 3.710

Review 3.  Seminoma testis with elevated serum beta-HCG--a category of germ-cell cancer between seminoma and nonseminoma.

Authors:  K P Dieckmann; W Düe; H W Bauer
Journal:  Int Urol Nephrol       Date:  1989       Impact factor: 2.370

4.  Findings in lymph nodes of patients with germ cell tumours after chemotherapy and their relation to prognosis.

Authors:  R J Zuk; B J Jenkins; J E Martin; R T Oliver; S I Baithun
Journal:  J Clin Pathol       Date:  1989-10       Impact factor: 3.411

5.  Prognosis of testicular tumour since the introduction of complex therapy.

Authors:  D Frang; L Farkas; F Götz; J Székely
Journal:  Int Urol Nephrol       Date:  1989       Impact factor: 2.370
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.